ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Steven Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.